Ami Organics (Mid Cap - High Growth) Share Target 2025, 2026 To 2035
|
Ami Organics Limited |
|||
|
Price: ₹2,006.25 (+1.74%) | ||
| 52 Week Low: ₹1,004.45 52 Week High: ₹2,395.00 |
|||
| Market Capital: 8,276.75 Crore (Midcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Ami Organics Share Price Target For 2025
- 1.1.1: Ami Organics Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Ami Organics Share Price Target For 2026
- 1.2.1: Ami Organics Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Ami Organics Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Ami Organics Brief Company Overview
- 4: Ami Organics Financial Performance
- 4.0.1: Is Ami Organics A Good Buy For Long Term?
Ami Organics, a Mid Cap company in the Specialty Chemicals Industry has delivered 98.7% returns in 3-year showing 43.2% quarterly revenue growth with 11.4% profit margin, making it a High Growth stock.
To predict the Ami Organics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Ami Organics Share Price Target For 2025
The line chart displays the monthly closing prices of Ami Organics with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ami Organics shares in 2025, see the table below.
Ami Organics Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 2275.0 (+13.39%) | Price Action: 11 Dec 2024 High |
| 2025 Target 2 | 2244.45 (+11.87%) | Price Action: 06 Dec 2024 High |
| 2025 Target 1 | 2216.45 (+10.47%) | Price Action: 05 Dec 2024 Low |
| Current Price | 2006.25 | Ami Organics's share price as of 23 Jan 2025 |
| Stop Loss 1 | 1893.83 (-5.61%) | Technical Indicator: MA100 |
| Stop Loss 2 | 1870.6 (-6.77%) | Price Action: 31 Oct 2024 Low |
| Stop Loss 3 | 1823.0 (-9.14%) | Price Action: Sep 2024 High |
Short-Term Technical Outlook
Current Technical Position: Ami Organics is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹2117.67 serves as the nearest technical reference point.
Historical Returns: 3-month: -0.28% | 6-month: +47.39% | 1-year: +69.51%
Ami Organics Share Price Target For 2026
The line chart displays the monthly closing prices of Ami Organics with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ami Organics shares in 2026, see the table below.
Ami Organics Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 3089.44 (+53.99%) | Price Action: Chart |
| 2026 Target 2 | 3031.84 (+51.11%) | Price Action: Chart |
| 2026 Target 1 | 3001.82 (+49.62%) | Fibonacci Extension Level 64.90% |
| Current Price | 2006.25 | Ami Organics's share price as of 23 Jan 2025 |
| Stop Loss 1 | 1758.95 (-12.33%) | Price Action: 26 Sep 2024 High |
| Stop Loss 2 | 1731.0 (-13.72%) | Price Action: 10 Oct 2024 High |
| Stop Loss 3 | 1712.85 (-14.63%) | Price Action: 25 Sep 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Ami Organics is currently trading at 72.0% of its 52-week range (₹1004.45 - ₹2395).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +69.51% | 3-year: +98.66% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Ami Organics Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹2,006.25 | ||
| 2025 | ₹3,054.25 | +52.23% | ₹3,100.06 |
| 2026 | ₹4,935.29 | +61.58% | ₹5,009.32 |
| 2027 | ₹7,040.67 | +42.65% | ₹7,146.28 |
| 2028 | ₹9,496.84 | +34.88% | ₹9,639.29 |
| 2029 | ₹12,371.01 | +30.26% | ₹12,556.58 |
| 2030 | ₹15,029.36 | +21.48% | ₹15,254.80 |
| 2031 | ₹18,279.39 | +21.62% | ₹18,553.58 |
| 2032 | ₹24,633.90 | +34.76% | ₹25,003.41 |
| 2033 | ₹28,037.00 | +13.81% | ₹28,457.56 |
| 2034 | ₹36,692.93 | +30.87% | ₹37,243.32 |
| 2035 | ₹42,455.04 | +15.7% | ₹43,091.87 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Ami Organics Brief Company Overview
Ami Organics Limited: A Pharmaceutical Leader Ami Organics Limited (NSE: AMI Organics) is a leading Indian pharmaceutical company founded in 2004. Key Products and Services: Research and Development Manufacture Sale of pharmaceutical intermediates ...
Specialty chemicals for various industries Export of products Ami Organics offers about 520 pharmaceutical intermediates used in various applications, including anti-cancer, anti-psychotic, and anticoagulant formulations. Diverse Product Range: Agrochemicals Cosmetics Polymers Parabens and parabens formulations Salicylic acid Industry Reputation: Ami Organics has established a strong reputation in the industry for its quality products and customer satisfaction. Commitment: The company is committed to innovation, sustainability, and ethical practices.Ami Organics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 8,276.75 Crore | Market valuation of Ami Organics's shares. |
| Revenue (TTM) | 814.8 Crore | Total revenue generated by Ami Organics over the past twelve months. |
| Net Income (TTM) | +93.17 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +17.05% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +11.43% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+43.2% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.5 | Company's total debt divided by total shareholder equity. |
| Total Debt | 6.16 Crore | Sum of Ami Organics's current & long-term financial obligations. |
| Total Cash | 279.51 Crore | Total amount of liquid funds available to Ami Organics. |
| Beta | -0.06 | Beta is less than 1 indicating that the Ami Organics's price is less volatile than the market. |
Is Ami Organics A Good Buy For Long Term?
Ami Organics (market cap: ₹8,276.75 crore), while showing strong recent performance (YTD returns: 85.48%), presents a mixed picture for long-term investors. High growth in the last two quarters (Q2 2024-25 revenue up 43.2%) and a healthy profit margin (11.43%) are positive. However, the limited historical data (0% returns over 3 and 5 years) and relatively low net profit (₹93.17 crore on ₹814.8 crore revenue) warrant caution. Its low debt (₹6.16 crore) and substantial cash balance (₹279.51 crore) are reassuring. Overall, it's an average buy for the long term; further investigation is recommended before significant investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
